PT-141

CLASSIFICATION Melanocortin Receptor Agonists
ACNE No
WATER RETENTION No
HBR No
HEPATOTOXICITY No
AROMATIZATION No
MANUFACTURER Deus Medical
LAB TEST See Document
WAREHOUSE EU Warehouse 2
SUBSTANCE Bremelanotide ,

PT-141 (Bremelanotide) is a widely used peptide primarily aimed at enhancing libido. A distinctive aspect of this compound is its suitability for both men and women. Although it is synthetically produced, PT-141 is completely safe. The administration of this solution may be recommended for men experiencing erectile dysfunction and for women with sexual disorders.

Research has revealed additional benefits of this peptide. PT-141 can stimulate melanin production, resulting in a significant tanning effect. Consequently, ongoing laboratory studies continue to broaden its potential applications.

Both men and women utilize PT-141. Unlike medications such as Viagra and Cialis, which primarily target blood vessels, Bremelanotide influences libido more directly through its active ingredients.

Effects of PT-141 use include:

To achieve the desired outcomes, it is essential to follow the instructions for PT-141 carefully.

For initial results, a subcutaneous administration of 0.3 milligrams is sufficient. This starting dose helps evaluate how the active components affect the body. If needed, the dosage can be adjusted upward, with the ideal range for a single administration being between 0.5 and 1.5 milligrams.

The first indications of Bremelanotide's effectiveness typically occur within a couple of hours post-administration, with peak effects realized after 3-4 hours. Overall, the active substance’s effects can last between 8-10 hours.

Research has confirmed that Bremelanotide exhibits all the characteristics mentioned in its instructions and effectively fulfills its intended purpose. However, some participants in studies experienced elevated blood pressure, leading to the discontinuation of further research. User feedback also indicates that an overdose could adversely affect blood pressure levels and result in hypertension. Local reactions, such as redness at the injection site, may occur but usually resolve within a few minutes and are generally not considered serious complications.